Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ashton

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
Clinical and Experimental Dermatology|March 22, 2001
Three cases of de novo dominant dystrophic epidermolysis bullosa associated with the mutation G2043R in COL7A1V Wessagowit, G H Ashton, R Mohammedi, et al.
Experimental Dermatology|April 17, 1999
A recurrent frameshift mutation in exon 19 of the type VII collagen gene (COL7A1) in Mexican patients with recessive dystrophic epidermolysis bullosaJ E Mellerio, J C Salas-Alanis, M Amaya-Guerra, et al.
The British Journal of Dermatology|January 20, 1999
A recurrent glycine substitution mutation, G2043R, in the type VII collagen gene (COL7A1) in dominant dystrophic epidermolysis bullosaJ E Mellerio, J C Salas-Alanis, M L Talamantes, et al.
British Medical Journal|January 8, 1977
Comprehensive clinical drug information service: first year's experienceD M Davies, C H Ashton, J G Rao, et al.
Circulation Research|November 1, 1986
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonistsJ H Ashton, J M Schmitz, W B Campbell, et al.
Psychopharmacology|December 19, 1977
Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal manH Ashton, J E Millman, R Telford, et al.
Regulatory Toxicology and Pharmacology : RTP|April 1, 1995
Talc: occurrence, characterization, and consumer applicationsR Zazenski, W H Ashton, D Briggs, et al.
Circulation|October 1, 1987
Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenosesJ H Ashton, M L Ogletree, I M Michel, et al.
ASAIO Transactions|July 1, 1986
Large-animal model of chronic congestive heart failure induced by intracoronary allylamineL S Beck, R D Strickland, B L Bagley, et al.
Molecular Cancer Therapeutics|December 7, 2006
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinibAlan Serrels, Iain R J Macpherson, T R Jeffry Evans, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
Clinical and Experimental Dermatology|March 22, 2001
Three cases of de novo dominant dystrophic epidermolysis bullosa associated with the mutation G2043R in COL7A1V Wessagowit, G H Ashton, R Mohammedi, et al.
Experimental Dermatology|April 17, 1999
A recurrent frameshift mutation in exon 19 of the type VII collagen gene (COL7A1) in Mexican patients with recessive dystrophic epidermolysis bullosaJ E Mellerio, J C Salas-Alanis, M Amaya-Guerra, et al.
The British Journal of Dermatology|January 20, 1999
A recurrent glycine substitution mutation, G2043R, in the type VII collagen gene (COL7A1) in dominant dystrophic epidermolysis bullosaJ E Mellerio, J C Salas-Alanis, M L Talamantes, et al.
British Medical Journal|January 8, 1977
Comprehensive clinical drug information service: first year's experienceD M Davies, C H Ashton, J G Rao, et al.
Circulation Research|November 1, 1986
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonistsJ H Ashton, J M Schmitz, W B Campbell, et al.
Psychopharmacology|December 19, 1977
Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal manH Ashton, J E Millman, R Telford, et al.
Regulatory Toxicology and Pharmacology : RTP|April 1, 1995
Talc: occurrence, characterization, and consumer applicationsR Zazenski, W H Ashton, D Briggs, et al.
Circulation|October 1, 1987
Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenosesJ H Ashton, M L Ogletree, I M Michel, et al.
ASAIO Transactions|July 1, 1986
Large-animal model of chronic congestive heart failure induced by intracoronary allylamineL S Beck, R D Strickland, B L Bagley, et al.
Molecular Cancer Therapeutics|December 7, 2006
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinibAlan Serrels, Iain R J Macpherson, T R Jeffry Evans, et al.
Pageof 17